What is the best medication for treating post‑burn pruritus in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Best Medicine for Post-Burn Itching

Gabapentin is the best medication for treating post-burn pruritus in adults, with doses ranging from 100-300 mg three times weekly (for dialysis patients) to 300 mg 1-3 times daily for burn patients, demonstrating superior efficacy compared to antihistamines like cetirizine.

Evidence-Based Recommendation

The most recent high-quality evidence strongly supports gabapentin as first-line therapy:

  • Gabapentin reduced itch by 92.9% over 14 days compared to cetirizine's 61.8% 1
  • When itch became protracted beyond 6 weeks, gabapentin maintained 89.4% effectiveness while cetirizine dropped to only 37.7% 1
  • Meta-analysis showed gabapentin improved VAS scores by 2.96 points (95% CI 1.20-4.73, p<0.001) compared to placebo or antihistamine 2
  • At 2 months, gabapentin achieved statistically greater improvements in both pruritus intensity and quality of life 3

Practical Dosing Algorithm

Start with:

  • Gabapentin 300 mg once daily, then titrate to 300 mg 1-3 times daily based on response 1, 3
  • For patients on dialysis: 100-300 mg post-dialysis three times weekly 4

If inadequate response after 2 weeks:

  • Increase to maximum tolerated dose (typically 300 mg three times daily)
  • Monitor for drowsiness as the primary side effect

Why Antihistamines Fail

The evidence clearly demonstrates antihistamine limitations:

  • Cetirizine is not effective in burn-related pruritus 4, 1
  • Over 70% of burn patients receive antihistamines (hydroxyzine or diphenhydramine most common), yet frequent switching occurs at median 27.75 days, indicating poor efficacy 5
  • Sedating antihistamines should be avoided long-term due to dementia risk, except in palliative care 4

Alternative Options (Second-Line)

If gabapentin is contraindicated or not tolerated:

Topical therapies:

  • Enalapril ointment (MD -0.70 on 0-4 scale, moderate-certainty evidence) 6
  • Topical doxepin (limited to 8 days, 10% body surface area, 12g daily maximum due to contact dermatitis risk) 4

Physical modalities:

  • Massage therapy (SMD -0.86, equating to 4.60-point VAS reduction) 6
  • Pulsed high-intensity laser (MD -0.51 on ISS scale) 6

Critical Pitfalls to Avoid

  1. Don't rely on antihistamines alone - they show poor efficacy in post-burn pruritus despite widespread use 1, 5

  2. Don't use topical capsaicin - not recommended for generalized pruritus of unknown origin, only for uraemic pruritus 4

  3. Don't use calamine lotion or crotamiton cream - no evidence supports their use 4

  4. Don't delay treatment - average initiation time is 16.75 days, but earlier intervention may improve outcomes 5

  5. Don't forget emollients - essential baseline therapy for xerosis that lowers itch threshold 4

Clinical Pearls

  • Controlling itch intensity directly improves sleep quality 1
  • Approximately 97% of burn patients present with moderate-to-severe itch, with 69% experiencing acute itch between weeks 1-4 1
  • The combination of gabapentin plus cetirizine offers no additional benefit over gabapentin alone 1
  • Response to antihistamines may be associated with gut microbiota composition, explaining variable individual responses 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.